ophthalmology

A steroid alternative may offer a new way to treat dry eye by restoring the eye’s natural protective defenses. Scientists at Baylor College of Medicine and Okayama University in Japan have developed an experimental eye drop that does more than calm inflammation. In mouse studies, it appeared to restore some of the eye’s own protective [...]

Scientific Reports, Published online: 22 May 2026; doi:10.1038/s41598-026-54663-1 Choroidal structure as predictor of macular changes and visual outcomes after panretinal photocoagulation in eyes with very severe NPDR and early PDR without center-involving DME

Researchers at Baylor College of Medicine and Okayama University in Japan have developed and tested in mice a promising new eye drop formulation for treating dry eye disease.

What if your eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore (NUS) are pioneering a revolutionary treatment for dry eye disease.

Scientific Reports, Published online: 20 May 2026; doi:10.1038/s41598-026-54067-1 Changes in pupil size and accommodation following prophylactic peripheral laser retinopexy: a prospective self-controlled study

Scientists in Australia have made an important discovery that may help explain why some people lose their eyesight much faster than others as they grow older. The research focuses on age-related macular degeneration, or AMD, a disease that damages the retina and slowly steals central vision from millions of older adults around the world. The […] The post New clues about blindness in older people …

Scientific Reports, Published online: 12 May 2026; doi:10.1038/s41598-026-48198-8 Estimation of glaucomatous impairment in the visual field, excluding the effect of posterior capsule opacification

IntroductionARHGEF12 variants, which regulate the RhoA/ROCK pathway, are associated with primary open-angle glaucoma (POAG) in individuals of African ancestry and may influence response to Rho-kinase inhibitors such as netarsudil.MethodsWe analyzed 1,844 African ancestry subjects with POAG, comparing baseline demographic and ocular phenotypes across ARHGEF12 genotype groups (non-carriers, heteroz…

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology(r), the medical journal of the American Academy of Neurology.

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults.

Pregnancy brings profound changes to a woman's body, including her eyes and retinas. During Healthy Vision Month, the American Society of Retina Specialists (ASRS) is urging pregnant women and those planning to become pregnant to understand how retinal conditions can develop or worsen during pregnancy and why prompt evaluation by a retina specialist can be sight- and life-changing.

National Eye Institute (NEI) scientists have found that the way the retina metabolizes glucose directly controls which genes get switched on and off in light-sensing photoreceptors.

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare inherited eye diseases

Ophthalmologists finally have a supplement formula proven to delay blindness. The catch is knowing exactly when to take it and which version to trust.

Scientific Data, Published online: 01 May 2026; doi:10.1038/s41597-026-07330-z EED-Astig: A Multimodal Dataset for Pediatric Astigmatism Severity Prediction

Researchers at Johns Hopkins Medicine say they have successfully demonstrated that disrupting an eye structure long suspected of blocking the growth and survival of transplanted nerve cells may help restore vision in people with optic nerve damage.

Madeleine Finlay sits down with science editor Ian Sample to hear about some of the winners of the Breakthrough Prize, which held its ceremony in LA last weekend. Each prize is worth $3m and they’re awarded in physics, maths and life sciences. Madeleine and Ian hear from molecular biologist Jean Bennett, who shared a life sciences prize for her work developing the world’s first FDA-approved gene …